Crescent Biopharma, Inc. logo

Crescent Biopharma, Inc. (CBIO)

Market Open
11 Sep, 14:42
NASDAQ (CM) NASDAQ (CM)
$
19. 69
+0.23
+1.1665%
$
759.97M Market Cap
- P/E Ratio
- Div Yield
38,198 Volume
- Eps
$ 19.46
Previous Close
Analysts:
Add Transaction
Day Range
19.55 20.29
Year Range
8.72 27.41
Want to track CBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Crescent Biopharma, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
NA
Nizar Araji National Bank Of Canada /FI/
3 $54 $50.52 -$3.48 -6.44%
Point72 Asset Management LP
Point72 Asset Management LP Point72 Asset Management LP
300,000 $3.56M $5.14M $1.58M 44.52%
Joseph Castro
Joseph Castro Nuveen LLC
47,629 $857,322 $937,815.01 $80,493.01 9.39%
Regan O'Neill
Regan O'Neill Burkehill Global Management LP
74,000 $844,340 $1.55M $700,780 83%
Drew Phillips
Drew Phillips Fortitude Family Office LLC
40 $735 $786.6 $51.6 7.02%
Kevin Roan
Kevin Roan Stempoint Capita LLP
182,382 $3.28M $3.62M $340,634.86 10.38%
Hui Fai Tam
Hui Fai Tam Caitong International Asset Management Co. Ltd.
21 $379 $413.2 $34.2 9.02%
Ilko Menkov
Ilko Menkov Vestal Point Capita LLP
1.63M $20.13M $32.38M $12.25M 60.88%
BRIANNE SHERGILL
BRIANNE SHERGILL Exome Asset Management LLC
127,769 $2.35M $2.19M -$157,156.15 -6.7%
Mark Schafer
Mark Schafer Police & Firemen's Retirement System of New Jersey
6,369 $114,642 $132,729.96 $18,087.96 15.78%
Yuen Man Lee
Yuen Man Lee Persistent Asset Partners Ltd.
10,968 $197,424 $227,805.36 $30,381.36 15.39%